Astera Labs (ALAB) Could Be 26% Below Fair Value As Earnings Views Improve

Astera Labs (ALAB) is back in focus after a strong positive shift in earnings estimates and analyst sentiment, which has coincided with the stock outperforming its Computer and Technology sector peers this year.

The recent shift in earnings expectations has played out against a share price that is now US$289.47. A 30 day share price return of 15.91% has helped offset a 90 day decline of 15.57%. This has contributed to a 61.21% year to date share price return and 58.87% total shareholder return over the past year, which suggests momentum has rebuilt after earlier weakness as investors reassess Astera Labs in light of the revised outlook.

Extend your research beyond Astera Labs by comparing it with hand picked 56 AI infrastructure stocks that are also tied directly to the build out of cloud and AI connectivity.

Astera Labs now combines strong recent earnings momentum with a sharp swing in sentiment and price. The bigger question for you is whether that quality is already fully reflected in the current US$289.47 share price.

Most Popular Astera Labs Narrative: 26.1% Undervalued

Astera Labs’ most followed narrative points to a fair value of about $391.77, which sits well above the recent $289.47 share price. That gap reflects a detailed view on how AI connectivity demand could translate into future earnings power.

Rapid ramp-up and continued customer diversification of the Scorpio P-Series and soon-to-launch Scorpio X-Series switches are driving increased dollar content per AI accelerator, establishing a higher baseline for revenues as Astera Labs moves from early product adoption to large-scale rack-level AI infrastructure deployments, which will materially impact top-line growth and revenue stability.

Read the complete narrative. Read the complete narrative.

Want to see what is sitting behind that confidence in Scorpio driven AI fabrics? The narrative leans heavily on aggressive revenue compounding and resilient margins. It also bakes in a rich earnings multiple that only a handful of chip companies usually carry.

At the core of this fair value is a set of analyst forecasts for revenue, earnings and profitability that run far ahead of the broader US market over the next few years. The narrative assumes strong annual revenue and earnings growth, relatively high profit margins, and a sizeable price premium on those projected 2029 earnings, all discounted back using an 11.18% rate. Together, these inputs are what produce the suggested fair value of about $391.77 per share.

Result: Fair Value of $391.77 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, Astera Labs still faces concentration risk around large hyperscalers and the possibility that rapid technology shifts or rival standards could weaken demand for its connectivity products.

Find out about the key risks to this Astera Labs narrative.

Another View On Astera Labs Valuation

The popular narrative frames Astera Labs as about 26.1% undervalued using bullish earnings forecasts and a rich 92.7x P/E assumption for 2029. The current picture using today’s P/E is very different. At 135.9x versus a fair ratio of 61.9x, the stock screens as expensive compared with both the US Semiconductor industry at 47.4x and peers at 73.9x. The gap raises a simple question for you: Is the premium you are paying today one you are comfortable holding through the next cycle?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment split between premium pricing and growth optimism around Astera Labs, now is a good time to look at the full picture yourself and decide how comfortable you are with the trade off between risks and rewards. To weigh both sides in one place, review the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Astera Labs?

If you stop with Astera Labs you could miss other opportunities that fit your style, so use the Simply Wall St screener to broaden your watchlist intelligently.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com